Sunho Biologics, Inc. (HKG:2898)
Hong Kong
· Delayed Price · Currency is HKD 6.40
0.00 (0.00%)
At close: Mar 10, 2026
Sunho Biologics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 171.17 | 78.99 | 125.07 | 1.82 | 10.67 |
| Short-Term Investments | 238.38 | 219.47 | 84.99 | - | - |
| Trading Asset Securities | - | 158.83 | - | - | - |
| Cash & Short-Term Investments | 409.55 | 457.28 | 210.07 | 1.82 | 10.67 |
| Cash Growth | -17.23% | 117.69% | 11435.81% | -82.93% | - |
| Other Receivables | 8.43 | 8.19 | 2.29 | 1.63 | 6.36 |
| Receivables | 8.43 | 8.19 | 2.29 | 1.63 | 6.36 |
| Inventory | 1.1 | 0.97 | 0.82 | 0.88 | 1.17 |
| Prepaid Expenses | 22.46 | 15.08 | 8.75 | 7.42 | - |
| Other Current Assets | 46.52 | 11.47 | 5.22 | 2.88 | 3.2 |
| Total Current Assets | 488.07 | 493 | 227.14 | 14.63 | 21.4 |
| Property, Plant & Equipment | 47.73 | 51.8 | 50.71 | 46.05 | 52.57 |
| Long-Term Investments | 0.91 | 0.91 | - | - | - |
| Other Intangible Assets | 10 | 10 | 10 | 10 | 10 |
| Other Long-Term Assets | 11.18 | 5.02 | 2.6 | 0.18 | 0.98 |
| Total Assets | 557.88 | 560.74 | 290.45 | 70.86 | 84.96 |
| Accrued Expenses | 6.69 | 6.98 | 5.71 | 8.16 | 4.62 |
| Short-Term Debt | 61.3 | 34.3 | - | - | - |
| Current Portion of Long-Term Debt | - | - | - | 4.82 | - |
| Current Portion of Leases | 4.4 | 2.25 | 2.18 | - | 2.45 |
| Current Income Taxes Payable | 0.03 | 0.07 | 0.05 | 0.06 | 0.05 |
| Other Current Liabilities | 1.65 | 0.56 | 379.72 | 53.12 | 50.98 |
| Total Current Liabilities | 74.08 | 44.15 | 387.66 | 66.15 | 58.1 |
| Long-Term Debt | - | - | - | 6.21 | 158.41 |
| Long-Term Leases | 2.54 | 4.65 | 6.9 | - | - |
| Total Liabilities | 76.62 | 48.8 | 394.56 | 72.36 | 216.51 |
| Common Stock | 0.52 | 0.52 | 0.32 | 0.32 | 0.32 |
| Additional Paid-In Capital | 679.19 | 667.46 | - | - | - |
| Retained Earnings | -446.28 | -408.08 | -328.12 | -195.42 | -143.43 |
| Treasury Stock | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| Comprehensive Income & Other | 247.85 | 252.05 | 223.7 | 193.62 | 11.58 |
| Shareholders' Equity | 481.27 | 511.94 | -104.11 | -1.5 | -131.55 |
| Total Liabilities & Equity | 557.88 | 560.74 | 290.45 | 70.86 | 84.96 |
| Total Debt | 68.24 | 41.2 | 9.07 | 11.03 | 160.86 |
| Net Cash (Debt) | 341.3 | 416.09 | 200.99 | -9.2 | -150.19 |
| Net Cash Growth | -26.60% | 107.02% | - | - | - |
| Net Cash Per Share | 2.26 | 3.25 | 2.16 | -0.10 | -1.65 |
| Filing Date Shares Outstanding | 151.87 | 150.67 | 150.67 | 91 | 91 |
| Total Common Shares Outstanding | 151.87 | 150.67 | 94 | 91 | 91 |
| Working Capital | 413.99 | 448.85 | -160.52 | -51.52 | -36.7 |
| Book Value Per Share | 3.17 | 3.40 | -1.11 | -0.02 | -1.45 |
| Tangible Book Value | 471.27 | 501.94 | -114.11 | -11.5 | -141.55 |
| Tangible Book Value Per Share | 3.10 | 3.33 | -1.21 | -0.13 | -1.56 |
| Machinery | - | 57.59 | 56.51 | 52.71 | 52.53 |
| Construction In Progress | - | 0.61 | 1.05 | 2.83 | 0.72 |
| Leasehold Improvements | - | 0.49 | 0.49 | 0.49 | 0.49 |
Source: S&P Capital IQ. Standard template. Financial Sources.